B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Tofacitinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Tofacitinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

baricitinib
16 shared targets
decernotinib
15 shared targets
ruxolitinib
31 shared targets
upadacitinib
11 shared targets
azd
18 shared targets
ucn
16 shared targets
ripasudil
8 shared targets
cerdulatinib
9 shared targets
midostaurin
35 shared targets
pf
17 shared targets
Loading evidence profile...

This evidence profile for Tofacitinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.